GPR143 and Parkinson disease: The GPR143 ligand, L-DOPA, is produced during melanin synthesis and Parkinson’s disease patients taking L-DOPA showed reduced/delayed onset of AMD (Brilliant et al., 2016), suggesting that signalling from GPR143 might protect from AMD.